Previous close | 1.6700 |
Open | 1.6500 |
Bid | 1.7000 x 800 |
Ask | 1.7300 x 1000 |
Day's range | 1.6500 - 1.7900 |
52-week range | 1.2100 - 3.0800 |
Volume | |
Avg. volume | 1,576,088 |
Market cap | 318.011M |
Beta (5Y monthly) | 1.30 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights Significantly high institutional ownership implies Cerus' stock price is sensitive to their trading...
On March 14, 2024, William Greenman, President and Chief Executive Officer of Cerus Corp (NASDAQ:CERS), sold 125,926 shares of the company, according to a recent SEC Filing.
Cerus Corp (NASDAQ:CERS), a company specializing in the field of blood transfusion safety with its innovative INTERCEPT Blood System, has reported an insider transaction involving its Chief Operating Officer, Vivek Jayaraman.